NCM·Healthcare·$2.0B·#43 / 520 in Healthcare
ASTH Astrana Health Inc.
72SOLID
CATEGORY BREAKDOWN
GROWTH83
QUALITY48
STABILITY67
VALUATION100
GOVERNANCE90
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+56.4%
83
> 50% strong
Gross Margin
Revenue retained after direct costs
10.7%
14
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
198.7%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.6x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
59
99
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
20.3%
85
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-5.5%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ASTH WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ASTH's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.